Doubling the blockade for melanoma immunotherapy

Lorenzo Galluzzi; Alexander Eggermont; Guido Kroemer

doi:10.1080/2162402X.2015.1106127

Doubling the blockade for melanoma immunotherapy

Lorenzo Galluzzi
, Alexander Eggermont
, Guido Kroemer

Centre de Recherche des Cordeliers
Institut national de la santé et de la recherche médicale
Université Paris Cité
Sorbonne Université
Université Paris-Sud
Assistance publique – Hôpitaux de Paris
Karolinska Institutet

Research output: Contribution to journal › Editorial

9 Scopus citations

Original language	English
Article number	e1106127
Journal	Oncoimmunology
Volume	5
Issue number	1
DOIs	https://doi.org/10.1080/2162402X.2015.1106127
State	Published - 2016
Externally published	Yes

Keywords

CTLA4
PD-1
ipilimumab
metastatic melanoma
nivolumab
pembrolizumab

Access to Document

10.1080/2162402X.2015.1106127

Cite this

@article{cbbb1e03ad6745038fc38aa673907d74,

title = "Doubling the blockade for melanoma immunotherapy",

keywords = "CTLA4, PD-1, ipilimumab, metastatic melanoma, nivolumab, pembrolizumab",

author = "Lorenzo Galluzzi and Alexander Eggermont and Guido Kroemer",

year = "2016",

doi = "10.1080/2162402X.2015.1106127",

language = "English",

volume = "5",

journal = "Oncoimmunology",

issn = "2162-4011",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Doubling the blockade for melanoma immunotherapy

AU - Galluzzi, Lorenzo

AU - Eggermont, Alexander

AU - Kroemer, Guido

PY - 2016

Y1 - 2016

KW - CTLA4

KW - PD-1

KW - ipilimumab

KW - metastatic melanoma

KW - nivolumab

KW - pembrolizumab

UR - https://www.scopus.com/pages/publications/85016437322

U2 - 10.1080/2162402X.2015.1106127

DO - 10.1080/2162402X.2015.1106127

M3 - Editorial

AN - SCOPUS:85016437322

SN - 2162-4011

VL - 5

JO - Oncoimmunology

JF - Oncoimmunology

IS - 1

M1 - e1106127

ER -

Doubling the blockade for melanoma immunotherapy

Keywords

Access to Document

Other files and links

Fingerprint

Cite this